Taiwan Diabesity Study:Comparison With Mild Obese T2DM Patients Who Under Metabolic Surgery

Recruiting

• Conditions: Diabetes
• Interventions: Other: Observation of natural course of Diabetes Mellitus Type 2

• Registration Number: NCT02166372
• Lead Sponsor: Min-Sheng General Hospital

Brief Summary

T2DM has become a major health burden for our society. More and more data support the relative effectiveness of gastrointestinal metabolic surgery, known as bariatric surgery, in the remission of T2DM of BMI less35. The metabolic surgery guidelines of IDF recommend BMI over 27.5 in Asia.

The evidence reviewed above strongly points to the need for a large randomized, controlled trial to evaluate the risks and benefits of obesity surgery in the treatment of type 2 diabetes Mellitus. This study is expected to provide very significant findings about the natural course of diabetes in obese diabetic patients.

Detailed Description

This study will recruit 200 obese T2DM patients at MSGH, for a total of 1000 in Taiwan. The inclusion criteria are those with T2DM more than 6 months, under medical management in diabetes center, BMI over 25, age between 20 and 67 years. The goals of this study are to evaluate the nature course of the diabetes for 10 years. The primary outcomes for the treatment will be assessed every year after intervention and will be composite of CVD risk factor; specifically, the proportion of patients with HbA1c \< 7%, LDL cholesterol \< 100 mg/dl and systolic blood pressure \< 140 mmHg.

Study Timeline

• Study Start: 2014-03
• Status Verified: 2014-06
• Study First Submitted: 2014-06-16
• Study First Submitted QC: 2014-06-16
• Last Update Submitted: 2014-06-16
• Study First Posted: 2014-06-18
• Last Update Posted: 2014-06-18
• Primary Completion: 2024-12
• Study Completion: 2034-12

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 1000

Inclusion Criteria

• Diabetic Mellitus Type 2 medically controlled at Diabetes Center for at least six months
• BMI over 25
• age between 20 and 67

Read More

Exclusion Criteria

• Diagnosed with cancer within past five years
• HIV positive
• Active TB patients
• CV events in past six months
• serum cretinine over 2.0 mg/dl
• C-peptide bellow 1.0 ng/ml in past three months
• Diabetic retinopathy; vision bellow 0.1
• Cushing's syndrome
• History of organ transplant
• History of bariatric surgery
• History of alcohol or drug dependency in past five years
• Psychological problems likely to interfere with adherence to protocol

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Obese diabetic patients	Observation of natural course of Diabetes Mellitus Type 2	Diabetic patients with BMI over 25 Age 20 to 67 Diabetes medically controlled at our center for at least six months

Primary Outcome Measures

Name	Time	Method
Evaluate the natural course of the diabetes of obese patients over a period of 10 years	ten years

Trial Locations

Locations (1)

Min-Sheng General Hospital; 🇨🇳 Taoyuan City, Taiwan